1. Academic Validation
  2. Molecular cloning of human phosphomevalonate kinase and identification of a consensus peroxisomal targeting sequence

Molecular cloning of human phosphomevalonate kinase and identification of a consensus peroxisomal targeting sequence

  • J Biol Chem. 1996 Jul 19;271(29):17330-4. doi: 10.1074/jbc.271.29.17330.
K L Chambliss 1 C A Slaughter R Schreiner G F Hoffmann K M Gibson
Affiliations

Affiliation

  • 1 Institute of Metabolic Disease, Baylor Research Institute and Baylor University Medical Center, Dallas, Texas 75226, USA.
Abstract

Two overlapping cDNAs which encode human liver phosphomevalonate kinase (PMKase) were isolated. The human PMKase cDNAs predict a 191-amino acid protein with a molecular weight of 21,862, consistent with previous reports for mammalian PMKase (Mr = 21,000-22,500). Further verification of the clones was obtained by expression of PMKase activity in bacteria using a composite 1024-base pair cDNA clone. Northern blot analysis of several human tissues revealed a doublet of transcripts at approximately 1 kilobase (kb) in heart, liver, skeletal muscle, kidney, and pancreas and lower but detectable transcript levels in brain, placenta, and lung. Analysis of transcripts from human lymphoblasts subcultured in lipid-depleted sera (LDS) and LDS supplemented with lovastatin indicated that PMKase gene expression is subject to regulation by sterol at the level of transcription. Southern blotting indicated that PMKase is a single copy gene covering less than 15 kb in the human genome. The human PMKase amino acid sequence contains a consensus peroxisomal targeting sequence (PTS-1), Ser-Arg-Leu, at the C terminus of the protein. This is the first report of a Cholesterol biosynthetic protein which contains a consensus PTS-1, providing further evidence for the concept that early Cholesterol and nonsterol isoprenoid biosynthesis may occur in the peroxisome.

Figures